Safeguard Scientifics Inc. (NYSE:SFE) has earned a consensus broker rating score of 1.75 (Buy) from the four analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a hold recommendation, one has assigned a buy recommendation and two have assigned a strong buy recommendation to the company.
Brokers have set a one year consensus price target of $23.00 for the company, according to Zacks. Zacks has also given Safeguard Scientifics an industry rank of 223 out of 265 based on the ratings given to related companies.
Separately, Zacks Investment Research upgraded shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $14.00 price target for the company in a research report on Tuesday, June 14th.
In other news, CEO Stephen T. Zarrilli acquired 3,900 shares of the stock in a transaction on Wednesday, September 14th. The stock was acquired at an average cost of $12.75 per share, for a total transaction of $49,725.00. Following the completion of the transaction, the chief executive officer now directly owns 103,606 shares in the company, valued at $1,320,976.50. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 2.67% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in SFE. BlackRock Group LTD increased its position in shares of Safeguard Scientifics by 38.2% in the first quarter. BlackRock Group LTD now owns 113,075 shares of the company’s stock valued at $1,498,000 after buying an additional 31,256 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Safeguard Scientifics by 13.0% in the first quarter. JPMorgan Chase & Co. now owns 86,888 shares of the company’s stock valued at $1,151,000 after buying an additional 10,000 shares in the last quarter. State Street Corp increased its position in shares of Safeguard Scientifics by 0.9% in the first quarter. State Street Corp now owns 343,847 shares of the company’s stock valued at $4,559,000 after buying an additional 3,217 shares in the last quarter. Yakira Capital Management Inc. increased its position in shares of Safeguard Scientifics by 14.3% in the first quarter. Yakira Capital Management Inc. now owns 487,645 shares of the company’s stock valued at $6,461,000 after buying an additional 60,823 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Safeguard Scientifics by 5.8% in the first quarter. Geode Capital Management LLC now owns 133,856 shares of the company’s stock valued at $1,773,000 after buying an additional 7,330 shares in the last quarter. Institutional investors and hedge funds own 78.62% of the company’s stock.
Safeguard Scientifics (NYSE:SFE) opened at 12.96 on Wednesday. The firm has a 50-day moving average price of $13.62 and a 200-day moving average price of $13.31. Safeguard Scientifics has a 12 month low of $11.40 and a 12 month high of $18.07. The company’s market capitalization is $262.10 million.
Safeguard Scientifics (NYSE:SFE) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.45. During the same quarter last year, the company earned ($0.91) earnings per share. On average, equities analysts anticipate that Safeguard Scientifics will post $0.24 earnings per share for the current fiscal year.
About Safeguard Scientifics
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.